Deliver Your News to the World Top Trading Small Cap Stocks: TAEC, ABHI, REGO, PRTN


JERICHO, NY, September 5, 2012, offers free real-time market quotes and level II access along with breaking news from leading North American stock exchanges. MNS Quotes pre-market alert provides a heads up on top gaining and most alerted small cap stocks from the OTC and Pink Sheet markets. The most alerted OTCBB stocks we are tracking include TAEC, ABHI, REGO, PRTN.

Todays Alternative Energy Corporation (OTC: TAEC) announced its entry into contract with Neptune Marketing Technologies LLC (NMT), a New Jersey company. This Letter of Intent is intended to formally express NMT’s desire to enter into a project finance agreement, lease and other agreements to
facilitate Todays Alternative Energy’s projects. TAEC is up 152.73% with a volume of 3,817,301. See who’s trading TAEC today on Level II in real-time at

AmbiCom Holdings, Inc. (OTC: ABHI) designs and develops wireless products for the wireless medical industry. Its wireless modules and devices are based on its application software, and Wi-Fi or Bluetooth technologies. The company purchases standard wireless products, and designs and develops
features and packaging to customize these products to their original equipment manufacture markets. Its wireless device products consist of routers, compact flash adapters/modules, USB adapters/modules, mini PCI modules, PCI express mini modules, and mobile wireless products. ABHI is up 136.00% with a volume of 12,000. Check the ABHI stock price in real-time for free at

Realgold International, Inc. (OTC: REGO) intends to acquire or merge with an operating entity. Previously, the company published multimedia software products. The company was formerly known as Piranha Ventures, Inc. and changed its name to Realgold International, Inc. in December 2011. Realgold International, Inc. was founded in 1994 and is based in Taman Melaka Raya, Malaysia. REGO is up 47.14% with a volume of 200. Get free real-time information on REGO at

Pristine Solutions Inc. (OTC: PRTN) announced that the Company has entered into an agreement with RoxSan Pharmacy Inc. to provide continued specialized compound prescription of Homatropine in a novel oral suspension (“Tropine 3”) to support planned FDA compliant Clinical trial participants.  Tropine 3 is a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women. PRTN is up 25.98% with a volume of 20,870,228. See exclusive profile information on PRTN at

For more on what’s moving in the markets and free real-time / level 2 market quotes see
This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid SmallCapNewsRelease one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor’s reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.

(516) 942-4910


 MNS Quotes
 Small Cap news

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.